P-glycoprotein attenuating effect of human intestinal fluid

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Gastrointestinal Physiology

Background:

• P-glycoprotein (P-gp) is a key efflux transporter in the intestinal epithelium, influencing drug absorption and bioavailability.
• Standard in vitro models often use buffer solutions that may not fully replicate the physiological environment of the human gut.

Purpose of the Study:

• To investigate the impact of human intestinal fluid (HIF) on P-glycoprotein (P-gp)-mediated efflux of drugs.
• To determine if HIF affects the transport of model compounds across intestinal cell monolayers.

Main Methods:

• Human intestinal fluid (HIF) was collected from healthy volunteers.
• Caco-2 cell monolayers were used to model intestinal absorption and efflux.
• Cyclosporin A (CsA) served as a P-gp substrate to assess efflux transport in the presence of varying HIF concentrations.

Main Results:

• HIF significantly decreased the secretory transport of CsA, indicating an attenuation of P-gp efflux.
• HIF moderately increased absorptive transport of CsA without compromising cell monolayer integrity.
• A potential gender-specific effect of HIF on CsA transport was observed.

Conclusions:

• The use of simple buffer solutions may overestimate the role of P-gp efflux in vitro.
• Unidentified components within HIF can modulate P-gp mediated intestinal efflux.
• Further research is needed to elucidate the clinical relevance of HIF's P-gp modulating effects.